Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By Surgery
Clinical trial NCT00541086 · UNKNOWN
Trial details
- NCT number
- NCT00541086
- Sponsor
- Gruppo Italiano Mammella (GIM)
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2020-07-01
- Enrollment
- 3697
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.